Background: There are several validated risk factors for breast cancer. However the legitimacy of elevatedfasting blood glucose (FBG) is not well established. This study was designed to assess this parameter as a riskfactor for breast cancer among pre- and post-menopausal women. Materials and
Methods: This case-controlstudy was conducted at Department of Biochemistry, University of Karachi from June 2010 to August 2014.Simple random sampling technique was used to collect data of study subjects comprising 175 diagnosed breastcancer patients with positive histopathology from Breast Clinic, surgical unit-1, Civil Hospital, Karachi and 175healthy controls from various screening programs. Blood samples were analyzed for FBG and serum insulin.
Results: FBG, HOMA-IR, systolic and diastolic blood pressure were significantly raised in breast cancer caseswhen compared to control subjects. Cases and controls were further categorized in to two groups using cutoffvalue of 110mg/dl to distinguish subjects into normal fasting glucose (<110mg/dl) and having impaired fastingglucose (≥110-≤125 mg/dl) or diabetes (≥126 mg/dl). Odds ratios were found to be 1.57, 2.15 and 1.17 in overall,pre-menopausal and post-menopausal groups, respectively. (all p < 0.05).
Conclusions: A statistically significantrisk of breast cancer exists in women having elevated fasting blood glucose levels, corresponding to prediabetesand diabetes, among pre and postmenopausal ages, with comparatively greater effects in the premenopausalgroup.